Philippe Cattin | Biomedical Engineering | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Philippe Cattin | Biomedical Engineering | Best Researcher Award

University of Basel | Switzerland

Dr. Philippe Cattin is a distinguished full professor at the University of Basel, Switzerland, with over two decades of academic and research excellence in computer science, robotics, and medical technology. He earned his MSc in Computer Science and PhD in Robotics from ETH Zürich under the mentorship of renowned professors Ueli Maurer and Gerhard Schweitzer, establishing a strong foundation in computational and engineering sciences. His professional journey began as a doctoral researcher at ETH Zürich, followed by roles as junior researcher and senior researcher in the Computer Vision Laboratory before joining the University of Basel, where he advanced from assistant professor to full professor. His research interests focus on medical image analysis, computer vision, robotics, and the integration of virtual reality and deep learning in healthcare. Skilled in advanced algorithms, 3D visualization, VR-based surgical planning, and deep learning architectures, he has pioneered real-time volume rendering in VR and cutting-edge diffusion models for medical applications. His team’s contributions, including the development of Specto Medical and leadership in international competitions, have significantly advanced precision medicine and surgical training. Recognized for impactful innovations, publications in leading journals, and patent applications, Professor Cattin continues to shape the future of medical technology with global influence and academic leadership.

Profile: ORCID

Featured Publications

Neha Verma | Biotechnology | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms. Neha Verma | Biotechnology | Best Researcher Award

Sharda University | India

Neha Verma is a dedicated biotechnology researcher currently pursuing her Ph.D. at Sharda University, research experience in molecular biology, cell culture, spectroscopy, and bioinformatics. She has significantly contributed to cancer and osteoporosis research, with numerous publications in reputed journals and several patents to her credit. Her expertise encompasses a range of technical proficiencies including FACS, RT-PCR, HPLC, GC-MS, LC-MS, NMR, FT-IR, and advanced microscopy. She has actively participated in multiple national and international conferences and workshops, earning recognition for her work. She has co-authored book chapters with reputed publishers like Elsevier and is the recipient of prestigious awards such as Best Oral Presentation, Best Research Scholar, Silver Medal, and Young Scientist Award. Neha’s research blends experimental biology with computational techniques, reflecting a multidisciplinary approach. With a commitment to innovation and translational research, she aims to make meaningful contributions to biomedical sciences through novel therapeutic strategies.

Profile

Googlescholar

 Education

Neha Verma has built a strong academic foundation in the life sciences and biotechnology domain. She is currently pursuing her Ph.D. in Biotechnology with coursework from the Department of Life Sciences at Sharda University, where her research involves a multidisciplinary approach combining cell culturing, phytochemical analysis, and bioinformatics modeling. Prior to this, she earned her M.Sc. in Biotechnology from Himalayan University, where she developed core competencies in laboratory techniques and research methodologies. She began her academic journey with a B.Sc. in Life Sciences, which laid the groundwork for her interest in molecular biology and biochemistry. Throughout her education, she has consistently demonstrated academic excellence, contributing to scientific publications, attending scientific forums, and actively engaging in workshops and webinars related to spectroscopy, AI tools in science, and genetic disorders. Her academic path reflects a progressive learning trajectory that aligns closely with her current research goals and future aspirations in translational biotechnology

Experience

Neha Verma possesses over five years of extensive hands-on research experience in biotechnology, particularly in molecular biology, animal cell culturing, and the isolation and application of plant-based bioactives. Her professional exposure spans several advanced analytical and spectroscopic platforms such as HPLC, GC-MS, LC-MS, NMR, and FT-IR, used primarily for metabolite profiling and compound identification. She has worked on osteogenic differentiation and anticancer studies using plant extracts, evidenced by her co-authorship on high-impact journal articles and patented innovations. She has cultivated skills in experimental planning, data analysis using GraphPad and Excel, and bioinformatics tools like molecular docking and Swiss target prediction. Neha has participated in several high-end workshops funded by DST-SERB and DBT, as well as training programs on good laboratory practices and 3D cell culture technology. Her experience also includes contributing to international book chapters and conference presentations, showcasing her commitment to knowledge dissemination and interdisciplinary research collaboration.

Awards and Honors

Neha Verma has earned multiple prestigious awards recognizing her research excellence and scientific contributions. She received the Best Oral Presentation Award at a DBT-funded National Conference focused on Disease Diagnosis and Drug Development.  she was honored with the Best Research Scholar Award at the 6th International Conference on Cutting-edge Solutions in Science, Technology, Engineering, and Humanities. Her achievements also include receiving the Silver Medal at the 8th Annual Meeting of the International Association of Zoologists and the 5th International Conference on Recent Trends in Life Sciences and Biotechnology. Additionally, she was conferred the Young Scientist Award at the 4th Annual Meeting of the International Association of Zoologists. These accolades reflect her sustained efforts in innovative biotechnology research, her impactful presentations at scientific forums, and her leadership in driving translational outcomes. Her work in cancer and osteoporosis research has consistently gained academic and peer recognition.

Research Focus

Neha Verma’s research is centered on biotechnology applications in cancer and osteoporosis, particularly through the use of plant-derived bioactive compounds. She investigates the therapeutic potential of phytochemicals on osteogenic differentiation and anticancer activity, integrating molecular biology techniques like RT-PCR and FACS with spectroscopic tools such as HPLC, GC-MS, LC-MS, and NMR for compound analysis. Her studies also extend to bioinformatics, where she employs molecular docking and target prediction to elucidate mechanistic pathways. Neha’s scientific approach is highly interdisciplinary, blending traditional ethnopharmacology with modern experimental and computational methods. Her work has led to several granted and published patents focusing on anticancer and anti-osteoporotic agents. With contributions to journals, conferences, and book chapters, she aims to bridge the gap between natural products research and clinical translational outcomes in biotechnology.

Publications

 

Title: Occupational health hazards and wide spectrum of genetic damage by the organic solvent fumes at the workplace: A critical appraisal
Year: 2022
Citations: 10

Title: Recent Update on Active Biological Molecules in Generating the Anticancerous Therapeutic Potential of Garcinia mangostana
Year: 2022
Citations: 9

Title: A review on therapeutic mechanism of medicinal plants against osteoporosis: effects of phytoconstituents
Year: 2023
Citations: 6

Title: Sustainable synthesis of magnetic nanoparticles: biological applications of Cedrus deodara extract
Year: 2025
Citations: 1

Conclusion

Neha Verma is an accomplished biotechnology researcher whose interdisciplinary expertise, impactful publications, patents, and awards reflect her commitment to advancing therapeutic innovations in cancer and osteoporosis through integrated experimental and computational approaches.

Andreea-Teodora IACOB | Biomedical Applications of polymeric materials | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Andreea-Teodora IACOB | Biomedical Applications of polymeric materials | Best Researcher Award

Dr. Andreea-Teodora Iacob is a dedicated Lecturer PhD and Specialist Pharmacist at the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania. She has established a remarkable profile in the fields of pharmaceutical chemistry, drug design, and advanced polymeric systems for biomedical applications. With an impressive academic and professional trajectory, Dr. Iacob has contributed extensively to multidisciplinary research on heterocyclic compounds, nanostructured drug delivery systems, and wound healing materials. She holds multiple specialist certifications in pharmaceutical laboratory, clinical pharmacy, and the pharmaceutical-cosmetic industry. She has co-authored over 47 ISI-indexed publications, edited scientific volumes, and has been awarded several national and international accolades for her scientific contributions. Passionate about research, teaching, and collaboration, Dr. Iacob actively mentors students and serves as an editor and reviewer for reputed journals, while also engaging in national and international collaborative projects across pharmaceutical sciences.

Profile

🎓 Education

Dr. Iacob’s academic formation is grounded in pharmaceutical sciences, with a progressive specialization in both academic and clinical domains. She completed her Doctorate in Pharmaceutical Chemistry with research focusing on innovative biomaterials for wound management. In 2018, she earned certification as a Specialist Pharmacist in Pharmaceutical Laboratory from “Saint Spiridon” Clinical Hospital, Iași. In 2021, she added a second specialty in Clinical Pharmacy, and in 2025, she will complete her third specialty in Pharmaceutical and Cosmetic Industry. She enriched her academic background with a postdoctoral research fellowship (2019–2021) at the Faculty of Applied Chemistry and Materials Science in Bucharest, developing novel chitosan/PEO-based films for wound healing. Her academic journey is further enhanced by intensive involvement in national doctoral and postdoctoral training projects. Her education is marked by a continuous commitment to learning, research innovation, and application of chemistry and pharmacology for therapeutic benefit, laying the foundation for her dynamic research and teaching career.

🧪 Experience

Dr. Andreea-Teodora Iacob has over a decade of rich academic and clinical experience. Since February 2020, she serves as a Lecturer PhD in Pharmaceutical and Therapeutic Chemistry at UMF Iași, where she contributes to both undergraduate and postgraduate education. She began her clinical specialization as a pharmacist in 2018 and evolved through additional specializations in clinical pharmacy and pharmaceutical industries. From August 2019 to January 2021, she pursued postdoctoral research in chemical engineering, focusing on polymeric wound dressings. Her expertise spans drug synthesis, physicochemical characterization, nanotechnology, and biomedical formulations. Dr. Iacob has also participated in several European-funded training programs aimed at developing applied research and entrepreneurship skills. Her work encompasses laboratory management, student supervision, and interdisciplinary research. Additionally, she contributes to curriculum development and academic publishing, while maintaining active collaborations with national and international institutions. Her balanced experience in teaching, clinical practice, and research distinguishes her as a versatile pharmaceutical professional.

🏅 Awards and Honors

Dr. Iacob has received wide recognition for her innovative research. She won the Bronze and Silver Medals at EuroINVENT 2025 in Iași, acknowledging her contributions to wound healing and pharmaceutical formulations. She was among the five winners of the L’Oréal-UNESCO For Women in Science Young Talents Romania Program 2023, a prestigious award that supports early-career female researchers. Her papers have earned Best Paper Awards at multiple International Scientific Conferences, including “Applications of Chemistry in Nanosciences and Biomaterials Engineering.” With an H-index of 13 (WOS) and 16 (Google Scholar), her work has been cited over 1000 times, highlighting her influence in the scientific community. She also serves as a Guest Editor for Polymers and Pharmaceutics, and as a substitute member of the COST EU Action CA19140, promoting advanced ion technologies. These honors showcase her dedication to impactful research, leadership in academia, and commitment to promoting women in science.

🔬 Research Focus

Dr. Iacob’s research bridges pharmaceutical chemistry, nanotechnology, and regenerative medicine. Her expertise centers on the synthesis of heterocyclic compounds (azetidin-2-ones, thiazolidine-4-ones, azomethines, hydrazones) with therapeutic potential, including antimicrobial, antioxidant, anti-inflammatory, and cytotoxic activities. She is also deeply involved in the design and evaluation of polymeric biomaterials such as hydrogels, sponges, and films, especially chitosan-based systems, for skin and wound therapy. She has pioneered work on electrospun nanofibers and niosomes, exploring their structural, functional, and biological characteristics for use in chronic wound healing. Her work integrates advanced synthesis methods, spectral analysis (IR, NMR, HRMS), and in vitro biological evaluation. She contributes to eight national and two international research projects and collaborates with leading institutions across Europe. Her multidisciplinary research reflects a commitment to translational science, bridging fundamental chemistry with practical medical applications, especially in skin regeneration, controlled drug delivery, and therapeutic polymer design.

✅ Conclusion

Dr. Andreea-Teodora Iacob is an accomplished pharmaceutical chemist and educator whose impactful contributions in heterocyclic drug design, nanostructured wound therapies, and polymeric biomaterials—supported by high-impact publications, patents, national and international projects, and prestigious awards—make her a leading figure in pharmaceutical research and an outstanding nominee for the Best Researcher/Women Research Award.

Publications

Agota Apati | Stem Cell Based Disease Modelling | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Agota Apati | Stem Cell Based Disease Modelling | Best Researcher Award

Dr. Ágota Apáti, PhD, DSc, is a distinguished Hungarian molecular biologist and Senior Research Associate at the Institute of Molecular Life Sciences, Research Centre for Natural Sciences. She leads the Pluripotent Stem Cell Laboratory and is renowned for establishing Hungary’s first human pluripotent stem cell lab. With over 70 publications and an H-index of 25, her work is widely recognized internationally. Dr. Apáti’s research encompasses human iPSC-derived disease models, membrane transporters, and cellular signaling pathways, with implications in schizophrenia, diabetes, and rare syndromes. She has supervised numerous PhD students and maintains active roles in both national and international scientific societies. Her commitment to translational stem cell research and ethical scientific practice positions her as a leading figure in the field of regenerative medicine and cellular therapeutics.

Profile

🎓 Education

Dr. Ágota Apáti holds a Master of Science (MSc) degree in Chemistry from Eötvös Loránd University of Sciences, Budapest (1984–1989). She later pursued doctoral studies and earned her PhD from Semmelweis Medical University (1998–2003), focusing on molecular and cellular aspects of hematology and immunology. Her academic training blends rigorous biochemical education with advanced medical sciences, establishing a solid foundation for her research career in stem cell biology and cellular therapeutics. Through continuous engagement in teaching and supervising graduate students, she has also remained an integral part of academic development at Hungary’s premier institutions. Her strong interdisciplinary background supports her work on complex cellular processes and disease modeling, and she is also a Doctor of Science (DSc, 2024) from the Hungarian Academy of Sciences—an honor awarded for substantial contributions to biomedical research in Hungary.

🧪 Experience

With over three decades of research experience, Dr. Ágota Apáti began her scientific career as a Research Fellow at Semmelweis Medical University (1989–1993). She progressed through multiple institutions, including the National Institute of Haematology and Immunology (1993–2004) and the National Blood Service (2005–2013), where she led various molecular biology projects. Between 2013 and 2023, she was a Senior Research Associate and lab head at the Institute of Enzymology, Hungarian Academy of Sciences. Since 2023, she continues her leadership as Laboratory Head at the Institute of Molecular Life Sciences under HUNREN. She has consistently taught and mentored postgraduate students in biochemistry, hematology, immunology, and membrane biology. Dr. Apáti’s collaborative and interdisciplinary projects have helped develop multiple disease models and cellular assays. Her scientific leadership has been instrumental in expanding Hungary’s role in cutting-edge stem cell research and molecular diagnostics.

🏅 Awards and Honors

Dr. Ágota Apáti has been recognized both nationally and internationally for her contributions to biomedical research. Early in her career, she received the prestigious UNIDO award during the ICRO course on RNA structure and function in Trieste, Italy (1994). In 2024, she was awarded the Doctor of Science (DSc) degree by the Hungarian Academy of Sciences—a distinguished title granted to researchers with a substantial, impactful body of scientific work. Her membership in renowned scientific organizations, such as the International Society for Stem Cell Research (ISSCR), Hungarian Society of Biology, Hungarian Society of Biochemistry, and the Hungarian Medical Research Council’s Ethical Board for Human Reproduction, underscores her stature in the field. These accolades not only reflect her scientific excellence but also her contributions to ethical research practice, public health, and mentoring within the scientific community, cementing her reputation as a key contributor to molecular life sciences.

🔬 Research Focus

Dr. Apáti’s research centers on pluripotent stem cells, disease modeling, and cellular signaling. She specializes in generating and differentiating human induced pluripotent stem cells (iPSCs) into neuronal, cardiac, mesenchymal, and endothelial lineages. Her work extends into disease modeling for schizophrenia, arteriosclerosis, diabetes, DiGeorge syndrome, and Frank-Ter Haar syndrome using patient-derived iPSC lines and CRISPR-based genome editing. She has developed cellular reporter systems to study membrane transporter function and calcium signaling pathways, significantly advancing understanding in neuropsychiatric and cardiovascular disorders. Through integrative omics and 3D organoid models, Dr. Apáti’s lab explores metabolic and genetic dysregulation in human pathologies. Her translational research aims to identify drug targets and therapeutic strategies using patient-specific cell lines. She also investigates multidrug resistance in stem cells and cancer, contributing to better clinical interventions. Her multidisciplinary projects bridge fundamental biology with clinical relevance, making her a vital contributor to regenerative medicine and personalized therapy.

✅ Conclusion

Dr. Ágota Apáti is a trailblazing scientist whose pioneering work in human stem cell research, disease modeling, and membrane biology continues to shape translational medicine, with a sustained commitment to research excellence, scientific mentorship, and ethical innovation in biomedical sciences.

Publications

  • Haloperidol, Olanzapine, and Risperidone Induce Morphological Changes in an In Vitro Model of Human Hippocampal Neurogenesis

    Biomolecules
    2024-06 | Journal article | Author
    DOI: 10.3390/biom14060688
    CONTRIBUTORS: Bálint Jezsó; Sára Kálmán; Kiara Gitta Farkas; Edit Hathy; Katalin Vincze; Dzsenifer Kovács-Schoblocher; Julianna Lilienberg; Csongor Tordai; Zsofia Nemoda; László Homolya et al.

  • Partial Disturbance of Microprocessor Function in Human Stem Cells Carrying a Heterozygous Mutation in the DGCR8 Gene

    Genes
    2022-10 | Journal article | Author
    DOI: 10.3390/genes13111925
    CONTRIBUTORS: Dóra Reé; Ábel Fóthi; Nóra Varga; Orsolya Kolacsek; Tamas Orban; Agota Apat

  • A Novel Cell-Based Model for a Rare Disease: The Tks4-KO Human Embryonic Stem Cell Line as a Frank-Ter Haar Syndrome Model System

    International Journal of Molecular Sciences
    2022-08 | Journal article | Author
    DOI: 10.3390/ijms23158803
    CONTRIBUTORS: Loretta László; Hédi Maczelka; Tamás Takács; Anita Kurilla; Álmos Tilajka; László Buday; Vas Virag; Agota Apati
  • Synthesis and Systematic Investigation of Lepidiline A and Its Gold(I), Silver(I), and Copper(I) Complexes Using In Vitro Cancer Models and Multipotent Stem Cells

 

Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award


Dr. Ejaz Ahmad Khera is an Assistant Professor of Physics at The Islamia University of Bahawalpur, Pakistan, and an HEC-approved supervisor with a PhD in the characterization of materials for memory storage and neuromorphic applications using DFT. He has published over 30 high-impact international research articles and currently leads research at the Materials Modeling and Simulation Lab, where he supervises MPhil and PhD students. His group is actively involved in developing efficient double perovskites for solar cell applications. In addition to his academic and research roles, Dr. Khera contributes to departmental administrative functions and has participated in multiple international conferences in physics and materials science. He is proficient in VASP, Wien2k, CASTEP, and other computational tools, reflecting his strong background in computational materials physics.

Profile

Education 🎓

Dr. Khera earned his PhD in Physics from The Islamia University of Bahawalpur (2016–2021), focusing on DFT-based characterization of materials for neuromorphic and memory applications. He holds an MPhil in Physics from Allama Iqbal Open University, Islamabad (2012–2014), and a Master of Science in Physics from Bahauddin Zakariya University, Multan (2007–2010). His academic foundation combines theoretical physics, computational modeling, and practical understanding of solid-state and condensed matter systems. He is trained in multiple simulation platforms including VASP, Wein2k, and CASTEP, and has built expertise in data analysis software like Origin and visualization tools like VESTA and Crystal Maker. His solid academic training has enabled him to mentor graduate students in computational material science and renewable energy research domains. Dr. Khera has also enhanced his academic exposure through participation in pedagogical and research methodology training programs.

Experience 👨‍🏫

Dr. Khera is currently serving as Assistant Professor of Physics at The Islamia University of Bahawalpur since March 2022, where he teaches undergraduate and postgraduate courses, leads research, and manages academic administration. From 2019 to 2021, he was a visiting lecturer at University of Education, Multan Campus, and previously taught physics at Admire Group of Colleges (2017–2021), Muslim Group of Colleges (2013–2017), and Educators Group of Colleges (2011–2013), focusing on undergraduate and higher secondary education. Over a decade of teaching experience has honed his expertise in delivering core physics concepts and mentoring students. In his academic tenure, Dr. Khera has also built research collaborations and guided MPhil and PhD students in materials modeling. His responsibilities have included curriculum design, academic planning, and seminar coordination. He is deeply engaged in academic development through active participation in physics conferences and workshops.

Awards & Recognitions 🏅

Dr. Khera received the Prime Minister Youth Laptop Scheme award from the Federal Government of Pakistan in 2018, recognizing his academic excellence and contribution to higher education. He was also granted the Punjab Government Scholarship under the Fee Reimbursement Scheme for Higher Education in 2017, awarded by the Government of Punjab. These honors reflect his academic merit, commitment to research, and service in the field of physics education. He has participated in multiple international and national-level conferences, including events hosted by The Islamia University of Bahawalpur and The Women University Multan. His consistent performance in academics and his role in teaching and research supervision have earned him institutional recognition. Additionally, his HEC-approved supervisor status further signifies his qualification and leadership in guiding advanced research projects in Pakistan. These accolades support his active involvement in national education development and scientific advancement in materials science.

Research Interests 🔬

Dr. Khera’s research is centered on computational materials science with a focus on density functional theory (DFT)-based investigations of electronic, optical, thermoelectric, and structural properties of novel materials. His primary interest lies in characterizing double perovskites (DPs), Heusler alloys, and vacancy-ordered compounds for use in solar cells, memory storage, brain-inspired neuromorphic systems, and energy harvesting applications. Using simulation tools like VASP, CASTEP, and Wien2k, he studies materials such as Ga₂PtX₆, Li₂ATlCl₆, and Na₂PtX₆ for their optoelectronic and thermoelectric performance. His recent publications explore halogen modification, spin polarization, and hybrid perovskites for sustainable technologies. His research group actively contributes to discovering lead-free, high-efficiency materials that align with global goals for clean and renewable energy. Dr. Khera also collaborates internationally, co-authoring papers with scientists across Asia and Europe, thereby advancing the field of computational physics and sustainable material development.

Publications

 

  • Probing the opto-electronic, thermoelectric, thermodynamic and elastic responses
    of lead-free double perovskite Li2ATlCl6 (A= Na and K) for potential photovoltaic
    and high-energy applications: A DFT study
    Reference: Qiguo Xiao, Abrar Nazir, Ejaz Ahmad Khera, Mumtaz Manzoor, Ramesh
    Sharma, Javed Rahman, Sabah Ansar, Farooq Ali
    Link: https://www.sciencedirect.com/science/article/pii/S0921510724006895

 

  • First principles investigation of structural, electronic, optical, transport properties
    of double perovskites X2TaTbO6 (X= Ca, Sr, Ba) for optoelectronic and energy
    harvesting applications
    Reference: Mudassir Ishfaq, Muniba Urooj, Muhammad Sajid, Khawar Ismail, Rimsha
    Baqeel, Ejaz Ahmad Khera, Rajwali Khan, Sattam Al Otaibi, Khaled Althubeiti, Hassan Ali,
    Ghulam Murtaza, Muhammad Jamil
    Link: https://www.sciencedirect.com/science/article/pii/S0022369724005675

 

 

Nathan Robert Wall | Medicine | Excellence in Research Award

Published on by Cognitive Scientist Awards

Dr. Nathan Robert Wall | Medicine | Excellence in Research Award

Dr. Nathan R. Wall is an accomplished academic, biomedical researcher, and military officer. He is currently an Associate Professor of Medicine at Loma Linda University School of Medicine and holds multiple leadership roles in research, oncology education, and national defense. With advanced degrees in biology, cancer biology, and business administration, he has dedicated his career to cancer research and military medical operations. Dr. Wall has served in multiple deployments with the California Army National Guard, including missions in Afghanistan, Poland, and Iraq. His military and academic excellence is recognized through numerous awards and honors. Dr. Wall combines rigorous research in molecular medicine with a passion for leadership, education, and national service. His extensive experience in academia, clinical research, and military command uniquely positions him at the intersection of science and strategic operations, contributing to both medical advancement and national security.

Profile

Education 🎓

Dr. Nathan R. Wall is currently pursuing a Master of Strategic Studies at the U.S. Army War College (2024–2026). He earned his MBA with a focus in Management from the University of Redlands (2006–2008), and a Ph.D. in Cancer Biology from Wayne State University (1996–2000), where he also completed an M.S. in Molecular Biology and Genetics. Prior to that, he obtained an M.S. in Biology (1992–1995) and a B.S. in Biology with a minor in Chemistry (1987–1991) from Walla Walla College (now Walla Walla University). His graduate training included mentorship under leading scientists like Dr. Ayad M. Al-Katib and Dr. Joan M. Redd. Across disciplines—from molecular biology to strategic leadership—Dr. Wall’s education reflects a commitment to interdisciplinary excellence, equipping him with the skills to navigate both biomedical research and complex military operations with strategic insight.

Experience 👨‍🏫

Dr. Nathan R. Wall has held academic appointments at Loma Linda University since 2008, currently serving as Associate Professor of Medicine in the Division of Human Anatomy. He also directs Research and Development at the James M. Slater Proton Treatment & Research Center and is Oncology Thread Director at the School of Medicine. Previously, he served in the Department of Biochemistry and Center for Health Disparities. Since 2008, Dr. Wall has simultaneously served in the California Army National Guard, rising through the ranks and completing deployments to Afghanistan, Poland, and Iraq in key command roles. He has also contributed as a scientific advisor for biotech firms and participated in Department of Defense medical research review panels. His interdisciplinary experience spans military medicine, molecular oncology, academic leadership, and national defense, making him a unique leader who bridges science, strategy, and service.

Awards & Recognitions 🏅

Dr. Wall’s exemplary service has earned him numerous military and civilian accolades. These include the Bronze Star Medal, NATO Medal, Afghanistan Campaign Medal, Global War on Terrorism Service Medal, and the Honorable Order of Saint Martin. He’s received multiple Army Commendation and Achievement Medals, along with California-specific honors like the California Medal of Merit and Drill Attendance Ribbon with multiple stars. Notably, he was recognized as “Citizen Warrior of the Month” by California ARNG Magazine in August 2018. Dr. Wall has also been honored with plaques and certificates from NATO, Bulgarian Joint Forces, and various military medical programs. His academic achievements include tenure at Loma Linda University and leadership roles in key training inspections. These honors reflect his unwavering commitment to excellence, leadership in medical readiness, and profound impact in both academic and military sectors.

Research Interests 🔬

Dr. Wall’s research focuses on cancer biology, with specific expertise in molecular mechanisms of disease, targeted therapies, and translational oncology. His work bridges basic science and clinical application, especially in the context of proton therapy and health disparities in underserved populations. At Loma Linda University, he leads interdisciplinary teams addressing tumor microenvironments, cancer signaling pathways, and innovative therapeutics. Dr. Wall also contributes to Department of Defense research as a peer reviewer, ensuring scientific rigor in funded medical studies. His research often integrates his military background, exploring how stress and trauma-related factors influence cancer biology and immune responses. As Director of R&D at a leading proton treatment center, he’s advancing precision medicine in oncology. Dr. Wall’s work is marked by its practical implications, scientific depth, and commitment to improving patient care—particularly for populations affected by health inequities or involved in military service.

Publications

  • Seco-Duocarmycin SA in Aggressive Glioblastoma Cell Lines

    International Journal of Molecular Sciences
    2025-03-19 | Journal article
    DOI: 10.3390/ijms26062766
    CONTRIBUTORS: Ann Morcos; Yeonkyu Jung; Ryan N. Fuller; Antonella Bertucci; Amy Nguyen; Quanqing Zhang; Tobias Emge; Kristopher E. Boyle; Nathan R. Wall; Marcelo Vazquez

  • A Comprehensive Review of the Antitumor Properties and Mechanistic Insights of Duocarmycin Analogs

    Cancers
    2024-09-27 | Journal article
    DOI: 10.3390/cancers16193293
    CONTRIBUTORS: Ann Morcos; Yeonkyu Jung; Joab Galvan Bustillos; Ryan N. Fuller; David Caba Molina; Antonella Bertucci; Kristopher E. Boyle; Marcelo E. Vazquez; Nathan R. Wal

  • A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection

    Vaccines
    2023-12-18 | Journal article
    DOI: 10.3390/vaccines11121865
    CONTRIBUTORS: Béla Dénes; Ryan Fuller; Wayne Kelin; Tessa Levin; Jaipuneet Gil; Aaren Harewood; Márta Lőrincz; Nathan Wall; Anthony Firek; William Langridg

Monia Orciani | Stem cells | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. Monia Orciani | Stem cells | Best Researcher Award

 

Profile

Education

On January 23, 2004, she was awarded a PhD in Biomedical Biotechnology from the Università Politecnica delle Marche. In 2001, she obtained her qualification as a Professional Biologist from the same institution. She completed her degree in Biological Sciences on March 10, 2000, graduating with top honors (110/110 cum laude).

Her native language is Italian. She is also proficient in English at the C1 level across listening, reading, interaction, speaking, and writing. She achieved the LanguageCert Level 2 Certificate in ESOL International (Speaking) (Expert C1) on January 20, 2023.

Work experience

Since July 15, 2019, she has been serving as an Associate Professor in the scientific-disciplinary sector BIO/17 – Histology at the Department of Clinical and Molecular Sciences, Università Politecnica delle Marche. She obtained her qualification as a Second-Tier Professor in Applied Biology (SSD 05/F1) on April 4, 2017, and later achieved First-Tier Professor qualification in Histology (SSD 05/H2) on November 18, 2020. Previously, she was a confirmed Researcher in Histology at the same department from April 13, 2015, following an initial appointment as a non-confirmed Researcher from November 1, 2011, to April 13, 2015. Before that, she held a research fellowship from June 3, 2011, to November 1, 2011, focusing on the use of stem cells in regenerative medicine. From June 1, 2010, to May 31, 2011, she was a research grant holder investigating skin-derived stem cells and their clinical prospects in regenerative therapy at the Department of Experimental and Clinical Medicine. Between November 1, 2003, and April 15, 2010, she conducted research on leukocyte ectoenzymes and their role in the pathogenesis, diagnosis, and treatment of selected human diseases at the Department of Molecular Pathology and Innovative Therapies – Histology. From July 16, 2001, to July 15, 2003, she held a research fellowship focused on monoclonal antibodies for in vivo applications at the Institute of Biology and Genetics. Her early experience includes an internship at the Institute of Biology, Genetics, and Biochemistry, University of Medicine and Surgery, Turin, from May 1, 2000, to December 1, 2000.

Teaching Experience

Since the academic year 2022/23, she has been the course leader for Histology in the Medicine and Surgery (MedTech) degree programme at the Università Politecnica delle Marche.

Since 2019/20, she has held the position of Histology lecturer within the integrated course Human Morphological Sciences for the Dental Hygiene degree programme at the same university.

She has also taught Histology within the integrated Histology-Anatomy-Physiology course for the Medical Radiology Techniques for Imaging and Radiotherapy degree programme during the academic years 2016/17–2018/19 and again in 2022/23.

Since 2022/23, she has been responsible for teaching Histology within the Morphology and Histology integrated course for the Midwifery degree programme.

Since 2017/18, she has been a Tutor for AFP (Basic Sciences and First Aid Area) in the Medicine and Surgery degree programme.

She has also been involved in structured and cross-disciplinary teaching for the PhD in Human Health and Biomedical Sciences since 2017/18.

Since 2017/18, she has led an elective teaching activity (ADE) titled “Biotechnologies for the Study of Normal Human Histology” in the Medicine and Surgery degree programme.

From 2019/20 to 2021/22, she taught Histology for the Dentistry and Dental Prosthetics degree programme.

Between 2016/17 and 2017/18, she was the English Language course leader for the Medical Radiology Techniques for Imaging and Radiotherapy degree programme.

She is proficient in Microsoft Office and holds an Expert C1 Level LanguageCert Certificate in ESOL International (Speaking), awarded on 20 January 2023.

In the academic year 2018/19, she taught Histology within the Biomedical Sciences 1 integrated course for the Physiotherapy degree programme.

Between 2017/18 and 2018/19, she led a seminar-based Histology course for the Dietetics degree programme.

Since 2016/17, she has been responsible for a seminar-based Histology course in the Nursing degree programme at the Fermo campus.

Between 2012/13 and 2018/19, she taught Histology within the Histology-Anatomy integrated course for the Biomedical Laboratory Techniques degree programme.

Since 2012/13, she has also been responsible for a seminar-based Histology course in the Nursing degree programme at the Macerata campus.

Research project

Professor Monia Orciani has been recognised with the ImmunoTools IT-FlowISiAM-Award 2024 for her research on “Searching for New Targets for Alzheimer’s Disease.” She is the Principal Investigator (PI) of the PRIN 2022 project titled “The Effects of Cortisol Excess on Neurogenesis in Alzheimer’s Disease: A Mandatory Footpath through Stem Cells (FORGETFUL)” (Project ID: 2022XF7XZF). In 2022, she secured funding from Boehringer-Ingelheim for a study on the “Role of Nintedanib on Mesenchymal Stem Cells Derived from Patients with Idiopathic Pulmonary Fibrosis (IPF),” in collaboration with Professor Martina Bonifazi. Additionally, she received the Fondo di Finanziamento Attività di Base di Ricerca (FFABR) – FFO grant in 2017 for her research on “Inflammation and Stem Cells: New Associations.” Her work on stem cells also led to a strategic university project (2017–2019) investigating “The Role of Stem Cells in Cutaneous Repair Deficiency in Patients with Endogenous and Exogenous Cushing’s Syndrome.”

Professor Orciani has contributed to several national research initiatives, including PRIN 2017, where she collaborated on “The Impact of Glucocorticoid Circadian Rhythm Disruption on Cardiovascular Risk and Immune Dysfunction: Pathophysiology and Novel Biomarkers of Glucocorticoid Exposure in Hypercortisolism and Hypocortisolism (CHRONO-IMAGE),” led by Professor Rosario Pivonello (Project ID: 2017HRTZYA_005). Earlier in her career, she was involved in FIRB-funded projects, such as the 2011 study on “Molecular Markers for Diagnosis, Prognosis, and the Development of New Therapeutic Strategies for Adrenal Carcinoma” (PI: Professor Roberto Di Primio, Project ID: RBAP1153LS_004) and the 2010 preclinical evaluation of “Scaffolds for Skeletal Tissue Regeneration” (PI: Professor Roberto Giardino, Project ID: RBAP10MLK7_003). In 2010, she participated in a PRIN project examining “The Interaction between Glucose and Bone Metabolism for the Cardiometabolic Characterisation of a Population of Young Obese Individuals” (PI: Professor Roberto Di Primio, Project ID: 201098WFZ2_006). Her involvement in FIRB dates back to 2001, where she contributed to a study on “Leukocyte Ectoenzymes and Their Role in the Pathogenesis, Diagnosis, and Therapy of Selected Human Diseases” (PI: Professor Fabio Malavasi, Project ID: RBNE01N4Z9_003).

Publication

  • 1. Pisciotta A, Di Tinco R, Bertani G, Orlandi G, Bertoni L, Pignatti E, Orciani M, Sena P,
    Bertacchini J, Salvarani C, Carnevale G. Human dental pulp stem cells (hDPSCs) promote the
    lipofibroblast transition in the early stage of a fibro-inflammatory process. Front Cell Dev Biol.
    2023;11:1196023
  • Preziuso A, Piccirillo S, Cerqueni G, Serfilippi T, Terenzi V, Vinciguerra A, Orciani M, Amoroso
    S, Magi S, Lariccia V. Exploring the Role of NCX1 and NCX3 in an In Vitro Model of
    Metabolism Impairment: Potential Neuroprotective Targets for Alzheimer’s Disease. Biology
    (Basel). 2023;12:1005.
  • Di Vincenzo M, Diotallevi F, Piccirillo S, Carnevale G, Offidani A, Campanati A, Orciani M.
    miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases:
    A Page Being Written: A Systematic Review. Int J Mol Sci. 2023;24:8502.
  • Di Vincenzo M, Orciani M. Special Issue “The Role of Mesenchymal Stem Cells on
    Inflammatory and Fibrotic Diseases”. Int J Mol Sci. 2023;24:8578.
  • Di Vincenzo M, Martino M, Lariccia V, Giancola G, Licini C, Di Benedetto G, Arnaldi G,
    Orciani M. Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels
    Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study
    Cushing’s Syndrome. Front Endocrinol (Lausanne). 2022;13:816229

Shilpa Kumari | Biotechnology | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms.Shilpa Kumari | Biotechnology | Best Researcher Award

 

Sharda University, India

Profile

Education

She is currently pursuing a Ph.D. at Sharda University since 2020, having completed her coursework with an impressive 84.5%. She holds an M.Sc. in Biotechnology from Chandigarh University, where she secured 79.6% in 2019. Prior to that, she earned her B.Sc. from HNB Garhwal Central University, Srinagar, in 2017 with a score of 66.7%. She completed her 12th grade in the Medical stream under CBSE in 2014 with 74.4% and her 10th grade in General Science in 2012, securing 75.5%.

 

Awards

She has been awarded the Sharda University Research Scholarship (SURS) by Sharda University since February 2021. She received a Silver Medal at the 8th Annual Meeting of the International Association of Zoologists and the 5th International Conference on Recent Trends in Life Sciences and Biotechnology held at Maharishi Markandeshwar (Deemed to be University), Haryana, in December 2024. Additionally, she was granted International Travel Support from the Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India, to present her research at the University Malay, Kuala Terengganu, Malaysia, in August 2024. She secured 2nd Prize at the Anveshan International Convention 2023-2024 (North Zone), organized by the Association of Indian Universities (AIU) in January 2024. Furthermore, she won the Best Oral Presentation Award at the National Conference on Disease Diagnosis and Drug Development Against Human Pathogens, sponsored by DBT and organized by Muthyammal College of Arts and Science in November 2023.

Book chapters

1. Shilpa Kumari, Neha Verma, Anil Kumar, Sunita Dalal, and Kanu Priya. “Functional
overrepresentation analysis and their application in microbial pathogenesis.” In Systems Biology
Approaches for Host-Pathogen Interaction Analysis, pp. 171-179. Academic Press, 2024.
2. Neha Verma, Shilpa Kumari, Anil Kumar, and Kanu Priya. “Advancements in systems biologybased analysis of microbial pathogenesis.” In Systems Biology Approaches for Host-Pathogen
Interaction Analysis, pp. 181-190. Academic Press, 2024

Publication

NORMA SILVA | Biotechnology | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr.Norma Silva | Biotechnology | Women Researcher Award

 

The university of Arizona, United States

Profile

Education

She holds a Biotechnology Engineering degree from the Technological Institute of Sonora (1991-1996) and a Master’s in Environmental Sciences and Sustainable Development from the Autonomous University of Sinaloa (2001-2004). She later earned a Ph.D. in Sciences with a Specialization in Biotechnology through the National Program (PNPC) of Biological Sciences of the Northwest, CONACYT, at the Technological Institute of Sonora (2010-2014). Additionally, she has obtained diplomas in teaching, generic competencies, and nutrition

Work experience

She worked as a Laboratory Technician at SABRITAS, S.A. de C.V. (1994-1998), where she was responsible for quality control of physicochemical parameters in raw materials, processes, and packaging lines. From 2001 to 2004, she served as a Professor at Colegio Sinaloa in Culiacán, teaching chemistry, biology, and food analysis. She then worked as an Adjunct Professor in the Department of Architecture and Environmental Engineering at the Technological Institute of Cajeme (ITESCA) from 2006 to 2008. Additionally, she held a dual role as a Professor and Academic Administrator in the Department of Biotechnology and Food Sciences at the Technological Institute of Sonora (ITSON) between 2001 and 2014. In 2011, she was an Adjunct Professor at Tecnológico de Monterrey, teaching Organic Chemistry in English. She later joined the University of Sonora (UNISON) as an Adjunct Professor from 2013 to 2016 and again in 2024. From 2017 to 2022, she worked as a Determined Research Professor at UNISON, focusing on biological sciences, particularly in the agri-food field and its connections to public health and the environment. Expanding her research internationally, she became an Associate Researcher at the University of Arizona’s Department of Environmental Sciences from 2021 to 2022. She continued her work there as a Visiting Professor with a Research Scholar position from 2023 to 2024 and is currently an Associate Researcher (2024-2025). Her research at the University of Arizona focuses on the innovation and development of biotechnological products using natural products.

Awards

She has received several distinctions throughout her career, including being recognized as a Distinguished Teacher at the Technological Institute of Sonora in 2006 and 2007. In 2017, she was honored as a Distinguished Citizen in CAJEME by the Interamerican University for Development in Cd. Obregón, Sonora. Her research excellence has been acknowledged by CONACYT’s National System of Researchers, where she was awarded the title of National Researcher Level C from January 1, 2016, to December 31, 2018. She advanced to National Researcher Level 1 in the area of Agricultural, Livestock, Forestry, and Ecosystem Sciences from 2019 to 2021 and continued at Level 1 in the area of Biotechnology and Agricultural Sciences for the period from January 1, 2021, to December 31, 2026.

Research Experience

She has extensive experience in research and development, demonstrating expertise in implementing technologies and innovative practices to enhance agricultural productivity, food security, and environmental sustainability. Her work focuses on utilizing scientific and technological tools to address complex challenges in the agri-food sector.

She completed a postdoctoral fellowship at the National Laboratory for Research in Food Safety (LANNIA), CONACYT, at the Center for Research in Food and Development (CIAD) (2016-2017), where she worked on the chemical and biological characterization of agro-industry products. Her research experience includes multiple research stays at CIAD: in 2004 at the Environmental Microbiology Laboratory (Culiacán Unit, Sinaloa), where she developed her master’s thesis on disinfection applications in mango products; in 2012 at the Antioxidant Laboratory (Hermosillo Unit, Sonora), where she evaluated the antioxidant capacities of agro-industrial products; and in 2013 at the Environmental Microbiology Laboratory (Culiacán Unit, Sinaloa), where she conducted her doctoral research on the characterization of antiviral studies of agro-industrial products.

Additionally, in 2016, she conducted a research stay at the Autonomous University of Mexico (UNAM), working at the Center for Genomic Sciences (CCG) in Cuernavaca, Morelos, focusing on the genomic characterization of bacteriophages isolated from agricultural valleys in Southern Sonora, Mexico.

Publication